News
SHANGHAI, China I May 15, 2025 I Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback